Olema Pharmaceuticals OLMA
NASDAQ OLMA
$7.27 -0.09 (-1.22%)
At close: Nov 10, 2026 · 4:00 PM EST

Olema Pharmaceuticals (OLMA) Return on Equity [ROE] (2020 - 2026)

Updated

Olema Pharmaceuticals' Return on Equity [ROE] was -44.82% in Q2 2026, down 5.76 percentage points from -39.07% a year earlier and down 6.17 percentage points from the prior quarter.

Analysis

Olema Pharmaceuticals (OLMA) Return on Equity [ROE] (2020 - 2026) Analysis & Trends

For FY2025, Return on Equity [ROE] at Olema Pharmaceuticals came in at -36.61%, up 2.48 percentage points from FY2024.

  • Return on Equity [ROE] has now increased for three consecutive years, though with a five-year change of -23.11 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Equity [ROE] was -39.10% in FY2024 (+3.72 pp), -42.81% in FY2023 (+0.65 pp), -43.46% in FY2022 (-20.64 pp) and -22.82% in FY2021 (-9.31 pp).
  • Quarterly Return on Equity [ROE] has moved between -59.07% (Q1 2023) and -19.36% (Q3 2021) over five years.
  • Compared with a year earlier, Return on Equity [ROE] was higher in four of the last eight quarters, with an average year-over-year change of -0.30 percentage points.
  • The best year-over-year quarter for Return on Equity [ROE] over five years was Q1 2024 (a gain of 18.54 percentage points); the worst was Q1 2023 (a drop of 30.42 percentage points).
  • Per Business Quant data, OLMA's Return on Equity [ROE] in the three quarters before Q2 2026 was -38.65% (Q1 2026), -41.34% (Q4 2025) and -45.92% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 19.33%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.63%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 21.60%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 72.13%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -31.17%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.66%
10 Olema Pharmaceuticals 734.94 Mn -1.15 Bn - -58.90%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -58.90%
Jun 30, 2026 -44.82%
Mar 31, 2026 -38.65%
Dec 31, 2025 -41.34%
Sep 30, 2025 -45.92%
Jun 30, 2025 -39.07%
Mar 31, 2025 -32.54%
Dec 31, 2024 -42.63%
Sep 30, 2024 -57.72%
Jun 30, 2024 -47.34%
Mar 31, 2024 -40.52%
Dec 31, 2023 -36.53%
Sep 30, 2023 -43.97%
Jun 30, 2023 -57.76%
Mar 31, 2023 -59.07%
Dec 31, 2022 -50.46%
Sep 30, 2022 -44.13%
Jun 30, 2022 -37.98%
Mar 31, 2022 -28.65%
Dec 31, 2021 -24.27%
API Access

Olema Pharmaceuticals Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=OLMA&period=max&api_key=YOUR_API_KEY